122 related articles for article (PubMed ID: 37708363)
1. Persistently Decreased Quality of Life and its Determinants in Previous Illicit Androgen Users.
Bulut Y; Brandt-Jacobsen N; Buhl L; Schou M; Frystyk J; Kistorp C; Rasmussen JJ
J Clin Endocrinol Metab; 2024 Jan; 109(2):e689-e697. PubMed ID: 37708363
[TBL] [Abstract][Full Text] [Related]
2. Serum Insulin-like Factor 3 Levels Are Reduced in Former Androgen Users, Suggesting Impaired Leydig Cell Capacity.
Rasmussen JJ; Albrethsen J; Frandsen MN; Jørgensen N; Juul A; Kistorp C
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2664-e2672. PubMed ID: 33693710
[TBL] [Abstract][Full Text] [Related]
3. Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids.
Rasmussen JJ; Schou M; Madsen PL; Selmer C; Johansen ML; Ulriksen PS; Dreyer T; Kümler T; Plesner LL; Faber J; Gustafsson F; Kistorp C
Am Heart J; 2018 Sep; 203():49-56. PubMed ID: 30015068
[TBL] [Abstract][Full Text] [Related]
4. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
5. Higher Myonuclei Density in Muscle Fibers Persists Among Former Users of Anabolic Androgenic Steroids.
Nielsen JL; Rasmussen JJ; Frandsen MN; Fredberg J; Brandt-Jacobsen NH; Aagaard P; Kistorp C
J Clin Endocrinol Metab; 2023 Dec; 109(1):e266-e273. PubMed ID: 37466198
[TBL] [Abstract][Full Text] [Related]
6. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.
Rasmussen JJ; Selmer C; Østergren PB; Pedersen KB; Schou M; Gustafsson F; Faber J; Juul A; Kistorp C
PLoS One; 2016; 11(8):e0161208. PubMed ID: 27532478
[TBL] [Abstract][Full Text] [Related]
7. Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study.
Smit DL; Buijs MM; de Hon O; den Heijer M; de Ronde W
Hum Reprod; 2021 Mar; 36(4):880-890. PubMed ID: 33550376
[TBL] [Abstract][Full Text] [Related]
8. Androgen deficiency in male patients diagnosed with ANCA-associated vasculitis: a cause of fatigue and reduced health-related quality of life?
Tuin J; Sanders JS; Buhl BM; van Beek AP; Stegeman CA
Arthritis Res Ther; 2013; 15(5):R117. PubMed ID: 24028544
[TBL] [Abstract][Full Text] [Related]
9. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
[TBL] [Abstract][Full Text] [Related]
10. Quality of life, self-esteem, fatigue, and sexual function in young men after cancer: a controlled cross-sectional study.
Greenfield DM; Walters SJ; Coleman RE; Hancock BW; Snowden JA; Shalet SM; DeRogatis LR; Ross RJ
Cancer; 2010 Mar; 116(6):1592-601. PubMed ID: 20186765
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in elderly men with androgen deficiency.
Finas D; Bals-Pratsch M; Sandmann J; Eichenauer R; Jocham D; Diedrich K; Schmucker P; Hüppe M
Andrologia; 2006 Apr; 38(2):48-53. PubMed ID: 16529575
[TBL] [Abstract][Full Text] [Related]
12. Recreational Physical Activity, Sitting, and Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study.
Oh H; Saquib N; Ochs-Balcom HM; Pfeiffer RM; Richey PA; Shadyab AH; Wild RA; Underland L; Anderson GL; Xu X; Trabert B
Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):97-107. PubMed ID: 34663616
[TBL] [Abstract][Full Text] [Related]
13. Reduced Quality of Life in Former Androgen Users: An Evolving Public-Health Concern.
Pope HG; Kanayama G
J Clin Endocrinol Metab; 2024 Apr; 109(5):e1400-e1401. PubMed ID: 37955864
[No Abstract] [Full Text] [Related]
14. Insulin sensitivity in relation to fat distribution and plasma adipocytokines among abusers of anabolic androgenic steroids.
Rasmussen JJ; Schou M; Selmer C; Johansen ML; Gustafsson F; Frystyk J; Dela F; Faber J; Kistorp C
Clin Endocrinol (Oxf); 2017 Sep; 87(3):249-256. PubMed ID: 28500659
[TBL] [Abstract][Full Text] [Related]
15. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
Kanayama G; Hudson JI; DeLuca J; Isaacs S; Baggish A; Weiner R; Bhasin S; Pope HG
Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Lev-Ran S; Imtiaz S; Taylor BJ; Shield KD; Rehm J; Le Foll B
Drug Alcohol Depend; 2012 Jun; 123(1-3):190-200. PubMed ID: 22143039
[TBL] [Abstract][Full Text] [Related]
17. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
18. Rate and Extent of Recovery from Reproductive and Cardiac Dysfunction Due to Androgen Abuse in Men.
Shankara-Narayana N; Yu C; Savkovic S; Desai R; Fennell C; Turner L; Jayadev V; Conway AJ; Kockx M; Ridley L; Kritharides L; Handelsman DJ
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32030409
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in prostate cancer patients taking androgen deprivation therapy.
Dacal K; Sereika SM; Greenspan SL
J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
[TBL] [Abstract][Full Text] [Related]
20. Use, Misuse and Abuse of Testosterone and Other Androgens.
Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 37051948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
